Psychological processes in the experience of hereditary angioedema in adult patients: an observational study.
C1 inhibitor
C1 inhibitor deficiency
Hereditary angioedema
Psychological processes
Stress
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
09 01 2021
09 01 2021
Historique:
received:
14
07
2020
accepted:
09
12
2020
entrez:
10
1
2021
pubmed:
11
1
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Hereditary angioedema associated to C1 inhibitor deficiency (C1-INH-HAE) is a pathological condition characterized by episodes of subcutaneous swelling and it is frequently associated with discomfort and social impairment of the patients, due to the anxiety experienced for an unpreventable manifestation of an attack during daily life. In children increased level of stress and alexithymia have been associated to C1-INH-HAE, and the latter correlated also with the severity of the disease. We hypothesized that the involvement of psychological issues may impact on the severity of C1-INH-HAE in adult patients as well, interfering with their ability to engage with the management of the disease. 28 adult patients with C1-INH-HAE were evaluated for clinical (C1-INH-HAE Severity Score) and psychological factors (alexithymia, emotion regulation, stress, patient health engagement, general severity index) by means of validated questionnaires. Mean age (standard deviation [SD]) was 45 (11) years and time from diagnosis was 20 (12) years. The mean C1-INH-HAE severity score was 6.4. Alexithymia was absent in 22 (78%) patients. Moderate and high stress levels were present in 17 (61%) and 4 (14%) patients, respectively. Moderate-high discomfort was experienced by 9 (36%) patients and a discomfort beyond the clinical attention threshold was shown by 3 (12%) patients. Stress correlated with patient health engagement and with psychological discomfort. In C1-INH-HAE, patients health engagement and moderate-high psychological discomfort are linked with stress but not with the severity of the disease or alexithymia. A better patient health engagement may be a target for psychological intervention in clinics to ameliorate the stress perceived by C1-INH-HAE patients.
Sections du résumé
BACKGROUND
Hereditary angioedema associated to C1 inhibitor deficiency (C1-INH-HAE) is a pathological condition characterized by episodes of subcutaneous swelling and it is frequently associated with discomfort and social impairment of the patients, due to the anxiety experienced for an unpreventable manifestation of an attack during daily life. In children increased level of stress and alexithymia have been associated to C1-INH-HAE, and the latter correlated also with the severity of the disease. We hypothesized that the involvement of psychological issues may impact on the severity of C1-INH-HAE in adult patients as well, interfering with their ability to engage with the management of the disease.
METHODS
28 adult patients with C1-INH-HAE were evaluated for clinical (C1-INH-HAE Severity Score) and psychological factors (alexithymia, emotion regulation, stress, patient health engagement, general severity index) by means of validated questionnaires.
RESULTS
Mean age (standard deviation [SD]) was 45 (11) years and time from diagnosis was 20 (12) years. The mean C1-INH-HAE severity score was 6.4. Alexithymia was absent in 22 (78%) patients. Moderate and high stress levels were present in 17 (61%) and 4 (14%) patients, respectively. Moderate-high discomfort was experienced by 9 (36%) patients and a discomfort beyond the clinical attention threshold was shown by 3 (12%) patients. Stress correlated with patient health engagement and with psychological discomfort.
CONCLUSIONS
In C1-INH-HAE, patients health engagement and moderate-high psychological discomfort are linked with stress but not with the severity of the disease or alexithymia. A better patient health engagement may be a target for psychological intervention in clinics to ameliorate the stress perceived by C1-INH-HAE patients.
Identifiants
pubmed: 33422102
doi: 10.1186/s13023-020-01643-x
pii: 10.1186/s13023-020-01643-x
pmc: PMC7796642
doi:
Substances chimiques
Complement C1 Inhibitor Protein
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
23Références
Orphanet J Rare Dis. 2017 Jan 10;12(1):5
pubmed: 28069032
Clin Nurs Res. 2020 Feb;29(2):117-126
pubmed: 29862835
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1132-1141
pubmed: 30033914
Allergy. 2011 Jan;66(1):76-84
pubmed: 20804470
Front Psychol. 2019 Nov 27;10:2609
pubmed: 31849744
Orphanet J Rare Dis. 2018 Jul 13;13(1):115
pubmed: 30005674
Int Arch Allergy Immunol. 2018;175(3):126-135
pubmed: 29393169
BMC Dermatol. 2012 Apr 26;12:4
pubmed: 22536794
Ann Allergy Asthma Immunol. 2014 Apr;112(4):371-5
pubmed: 24428960
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Psychother Psychosom. 2004 Mar-Apr;73(2):68-77
pubmed: 14767148
Eur Psychiatry. 2012 Nov;27(8):591-7
pubmed: 21334861
Front Psychol. 2015 Mar 27;6:274
pubmed: 25870566
Orphanet J Rare Dis. 2014 Mar 28;9:44
pubmed: 24678771